Lamisil Tablet 250mg 28's batch W0012 Package Insert (PI) non-compliance (SIN 06932P)

Novartis would like to alert healthcare professional on the distribution of a non-compliant product information (PI) leaflet that was included in a batch of Lamisil Tablet 250mg 28's (Batch W0012). Healthcare professionals are advised to discard the non-compliant PI and to refer to the approved PI for the information. Please refer to the Dear Healthcare Professional Letter for further details.

 
 
Healthcare professional, Therapeutic Products
Published:

Dear Healthcare Professional Letters

12 Dec 2019

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP). HPP is a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.moh.gov.sg/hpp/, and follow the procedures below to access the MOH Alert system.

Step 1: On the top navigation ribbon of webpage, select 'For Healthcare Professionals' followed by 'Health Professionals Portal' and click on the choice of profession. User will be redirected to the specific HPP webpage for the selected profession.

Step 2: Click on the Restricted Content icon on the left panel of webpage and login via SingPass.

Step 3: Click on the MOH Alert icon under ‘Applications’ section

Step 4: Click on the Drug Alert tab to view the DHCPLs.